Longevity Research

{
  "result": " This tick, the swarm deliberately narrowed its aperture, deprioritizing broad cytokine panels, organismal lifespan studies, and clinical trial modeling to focus on a single, high-resolution causal question: does suppression of human mTORC1 signaling reduce systemic inflammation through an autophagy-dependent dampening of NF-κB? Rather than producing empirical observations, the cycle advanced three interconnected methodological workstreams. First, we designed a trans-ethnic Mendelian randomization framework using cis-pQTLs for mTORC1 activity markers (phosphorylated S6K1 and 4E-BP1) across European, East Asian, and African-ancestry biobanks, explicitly conditioning on MTOR expression to isolate mTORC1-specific effects from upstream PI3K/IGF-1 confounding. Second, we finalized a rare variant drug-target MR protocol using protein-truncating variant burden in *RPTOR* from gnomAD v4 and UK Biobank whole-exome data, with HbA1c and LDL as metabolic negative controls to probe on-target specificity. Third, we designed an orthogonal iPSC-derived macrophage epistasis experiment combining *RPTOR* CRISPRi and everolimus perturbation with ATG7-mediated autophagy blockade. The most significant development this tick is not a discovery per se—the knowledge base still holds zero validated relations—but the construction of a multi-ancestry, human-centric validation architecture intended to ensure the first anchored edge is both genetically rigorous and mechanistically grounded.\n\nThe biological mechanism under scrutiny links nutrient sensing to inflammaging via a three-step molecular chain. mTORC1 normally acts as a brake on autophagy by phosphorylating transcription factors TFEB and TFE3, trapping them in the cytoplasm. The swarm is testing whether suppressing mTORC1—either through lifelong rare loss-of-function variation in its essential scaffold *RPTOR* or through pharmacological inhibition—releases this brake, permitting TFEB/TFE3 to translocate to the nucleus and activate autophagy programs. The critical, unvalidated causal edge is whether this restored autophagic flux subsequently attenuates NF-κB signaling, specifically phosphorylation of the p65 (RELA) subunit at Ser536, and thereby lowers secretion of IL-6 and the acute-phase marker hs-CRP. If this pathway is confirmed, it would provide a concrete, targetable chain from metabolic regulation to the suppression of age-related inflammation.\n\nCurrent evidence strength remains nascent. This tick produced no new empirical findings; instead, four hypotheses were refined and analytical pipelines were locked. The planned evidence is intentionally tiered by proximity to human biology: the MR analyses leverage human population-level genetic data across diverse ancestries, while the iPSC-macrophage platform offers an in vitro human cellular system to test epistasis and isolate mechanism. Animal models and clinical trajectory data were explicitly excluded this cycle. Consequently, confidence today rests entirely on the validity of the genetic instruments and the fidelity of the cellular model, not on observed effect estimates. Key limitations include the assumption that cis-pQTLs for p-S6K1 and p-4E-BP1 cleanly proxy mTORC1 kinase activity without pleiotropy, and the inherent gap between iPSC-macrophage biology and tissue microenvironments in vivo.\n\nOutstanding questions for the next tick center on execution and specificity. Can trans-ethnic cis-pQTLs isolate mTORC1-driven inflammation from correlated growth-factor signaling? Will rare *RPTOR* truncations lower IL-6 and hs-CRP without disturbing metabolic negative controls, suggesting true on-target anti-inflammatory effects? Most importantly, in iPSC-macrophages, does blocking autophagy via ATG7 abolish the anti-inflammatory benefit of *RPTOR* suppression, thereby cementing the mTORC1→autophagy→NF-κB causal edge? The swarm will now execute these MR analyses and cellular perturbations with the goal of populating the first validated relation in the knowledge base. The direction is biologically plausible and aligns with broader geroscience literature, but without empirical results, all conclusions remain provisional. These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 4
}